drug · small molecule
patient view →isoflurane
Phase 3updated 2mo agoby Sedana Medical AB🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 investigational indications.
targets
Potassium channel subfamily K member 2Potassium channel subfamily K member 9GABA-A receptor; anion channelGlycine receptor (alpha-1/beta)Potassium channel subfamily K member 10
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that